Who owns NAUTILUS BIOTECHNOLOGY INC?
- Ticker: NAUT
- CUSIP Number: 63909j108
Tip: Access positions for across all investors
Analyze quarterly positions in Nautilus Biotechnology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Nautilus Biotechnology stock
Who bought or sold NAUTILUS BIOTECHNOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AH Capital Management | 18M | $69M | 0% | Mar 2026 |
|
| Perceptive Advisors | 13M | $49M | 0% | Mar 2026 |
|
| Cercano Management | 7.2M | $28M | 0% | Mar 2026 |
|
| Madrona Venture Group | 6.0M | $12M | 0% | Dec 2025 |
|
| Vanguard Group | 2.6M | $5.1M | 7% | Dec 2025 |
|
| Vanguard Capital Management | 2.5M | $9.9M | 100% | Mar 2026 |
|
| Hartland & Co | 2.3M | $9.0M | 100% | Mar 2026 |
|
| Comprehensive Financial Management | 2.2M | $4.3M | 0% | Dec 2025 |
|
| Amazon | 1.5M | $5.7M | 0% | Mar 2026 |
|
| Millennium Management | 1.3M | $4.9M | 25% | Mar 2026 |
|
| Clarius | 1.2M | $2.4M | 0% | Dec 2025 |
|
| _Sentinel Trust Company, LBA______________ | 750k | $2.9M | 0% | Mar 2026 |
|
| Acadian Asset Management | 741k | $2.9M | 21% | Mar 2026 |
|
| Tikvah Management | 727k | $1.4M | 0% | Dec 2025 |
|
| Geode Capital Management | 604k | $2.3M | 8% | Mar 2026 |
|
| Goldman Sachs Group | 391k | $1.5M | 31% | Mar 2026 |
|
| Dimensional Fund Advisors | 329k | $1.3M | 15% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 306k | $1.2M | 100% | Mar 2026 |
|
| Renaissance Technologies | 260k | $507k | -74% | Dec 2025 |
|
| State Street Corporation | 201k | $392k | 13% | Dec 2025 |
|
| Hillman | 200k | $776k | 0% | Mar 2026 |
|
| BlackRock | 188k | $728k | -1% | Mar 2026 |
|
| Crewe Advisors | 136k | $528k | 0% | Mar 2026 |
|
| Bridgeway Capital Management | 130k | $254k | 4% | Dec 2025 |
|
| Qube Research & Technologies | 123k | $240k | 138% | Dec 2025 |
|
| Marshall Wace | 117k | $228k | 100% | Dec 2025 |
|
| CI Private Wealth | 115k | $445k | 0% | Mar 2026 |
|
| Northern Trust | 107k | $209k | -9% | Dec 2025 |
|
| Crown Advisors Management | 100k | $388k | 100% | Mar 2026 |
|
| Point72 Asset Management | 83k | $322k | 37% | Mar 2026 |
|
| Hrt Financial | 65k | $253k | 100% | Mar 2026 |
|
| Palumbo Wealth Management | 65k | $253k | 59% | Mar 2026 |
|
| Bank of America Corporation | 63k | $245k | 100% | Mar 2026 |
|
| Jane Street | 62k | $240k | -70% | Mar 2026 |
|
| Brevan Howard Capital Management | 61k | $235k | 100% | Mar 2026 |
|
| GSA Capital Partners | 55k | $212k | -56% | Mar 2026 |
|
| Citizens Financial Group | 50k | $194k | 100% | Mar 2026 |
|
| Morgan Stanley | 50k | $198k | 28% | Mar 2026 |
|
| Hsbc Holdings | 49k | $190k | 0% | Mar 2026 |
|
| Barclays | 48k | $94k | 0% | Dec 2025 |
|
| Jacobs Levy Equity Management | 46k | $180k | 100% | Mar 2026 |
|
| Catalyst Funds Management Pty | 46k | $180k | 100% | Mar 2026 |
|
| Ashton Thomas Private Wealth | 45k | $175k | 0% | Mar 2026 |
|
| Fayez Sarofim & Co | 45k | $88k | 0% | Dec 2025 |
|
| Caprock | 44k | $171k | 0% | Mar 2026 |
|
| Susquehanna International | 43k | $84k | 100% | Dec 2025 |
|
| Polen Capital Management | 40k | $157k | 100% | Mar 2026 |
|
| Lighthouse Investment Partners | 40k | $78k | 100% | Dec 2025 |
|
| Sei Investments | 39k | $150k | 100% | Mar 2026 |
|
| Presidio Capital Management | 35k | $135k | 0% | Mar 2026 |
|
| Captrust Financial Advisors | 34k | $66k | 100% | Dec 2025 |
|
| XTX Topco | 34k | $66k | -26% | Dec 2025 |
|
| Badgley Phelps Wealth Managers | 30k | $116k | 0% | Mar 2026 |
|
| Hudson Bay Capital Management | 30k | $115k | 55% | Mar 2026 |
|
| UBS Group | 27k | $104k | 421% | Mar 2026 |
|
| Callan Family Office | 26k | $101k | 0% | Mar 2026 |
|
| OMERS Administration Corporation | 25k | $95k | -77% | Mar 2026 |
|
| Virtu Financial | 24k | $46k | 20% | Dec 2025 |
|
| Diametric Capital | 23k | $89k | 100% | Mar 2026 |
|
| Citigroup | 21k | $82k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 17k | $64k | 100% | Mar 2026 |
|
| William Blair $ Company | 15k | $58k | 100% | Mar 2026 |
|
| FNY Investment Advisers | 14k | $54k | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 13k | $52k | -52% | Mar 2026 |
|
| Vanguard Capital Wealth Advisors | 13k | $50k | 0% | Mar 2026 |
|
| Symmetry Peak Management | 13k | $49k | 100% | Mar 2026 |
|
| CTC Alternative Strategies | 12k | $48k | 100% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 12k | $47k | 100% | Mar 2026 |
|
| Garde Capital | 11k | $43k | -39% | Mar 2026 |
|
| Nine Masts Capital | 10k | $40k | 100% | Mar 2026 |
|
| BFSG | 6.7k | $26k | 100% | Mar 2026 |
|
| Rockefeller Capital Management | 6.2k | $24k | 24% | Mar 2026 |
|
| FMR | 3.5k | $6.8k | -60% | Dec 2025 |
|
| TD Waterhouse Canada | 1.0k | $3.4k | 0% | Mar 2026 |
|
| Federation des caisses Desjardins du Quebec | 1.0k | $3.9k | 100% | Mar 2026 |
|
| Advisor Group Holdings | 715.00 | $1.4k | 0% | Dec 2025 |
|
| Wells Fargo & Company | 260.00 | $1.0k | -54% | Mar 2026 |
|
| Gill Capital Partners | 250.00 | $970.000000 | 100% | Mar 2026 |
|
| Your Advocates | 150.00 | $582.000000 | 0% | Mar 2026 |
|
| SBI Securities | 100.00 | $388.000000 | 100% | Mar 2026 |
|
| Royal Bank of Canada | 91.00 | $0 | -95% | Mar 2026 |
|
| CWM | 55.00 | $0 | -70% | Dec 2025 |
|
| Optiver Holding B.V. | 40.00 | $155.000000 | 0% | Mar 2026 |
|
| EverSource Wealth Advisors | 18.00 | $70.000200 | -63% | Mar 2026 |
|
| Covestor | 8.00 | $0 | 0% | Mar 2026 |
|
| Tower Research Capital | 5.00 | $10.000000 | -100% | Dec 2025 |
|
| Caitong International Asset Management | 1.00 | $4.000000 | 100% | Mar 2026 |
|
Who sold out of Nautilus Biotechnology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Alyeska Investment Group | Dec 2025 | 254k | $494k |
| Two Sigma Securities | Dec 2025 | 16k | $32k |
| Squarepoint Ops | Dec 2025 | 11k | $22k |
| Group One Trading | Dec 2025 | 3.9k | $7.6k |
| Jpmorgan Chase & Co | Sep 2025 | 2.1k | $1.8k |